APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Custom Synthetic Genes

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Custom Synthetic Genes Market Outlook and Growth Opportunities 2026

Report ID 173981760429 December 2025199 pages

Choose your research edition.

Industry ResearchCustom Synthetic Genes Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Custom Synthetic Genes Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Custom Synthetic Genes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Custom Synthetic Genes Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Custom Synthetic Genes Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Custom Synthetic Genes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Custom Synthetic Genes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Custom Synthetic Genes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Custom Synthetic Genes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Custom Synthetic Genes market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Custom Synthetic Genes market include Azenta Life Sciences, BBI, Bio Basic, DNA 2.0 (ATUM), Eurofins Genomics, Genescript, IDT, OriGene and SBS Genetech, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Custom Synthetic Genes market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Custom Synthetic Genes and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Custom Synthetic Genes revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Custom Synthetic Genes market.

Custom Synthetic Genes Segment by Company

Azenta Life Sciences

BBI

Bio Basic

DNA 2.0 (ATUM)

Eurofins Genomics

Genescript

IDT

OriGene

SBS Genetech

Thermo Scientific

Twist Bioscience

Custom Synthetic Genes Segment by Type

Above 5000 bp

3001- 5000 bp

1001 - 3000 bp

Below 1000 bp

Custom Synthetic Genes Segment by Application

Commercial

Academic Research

Custom Synthetic Genes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Custom Synthetic Genes status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Custom Synthetic Genes key companies, revenue, market share, and recent developments.

3. To split the Custom Synthetic Genes breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Custom Synthetic Genes market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Custom Synthetic Genes significant trends, drivers, influence factors in global and regions.

6. To analyze Custom Synthetic Genes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthetic Genes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Custom Synthetic Genes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthetic Genes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Synthetic Genes industry.

Chapter 3: Detailed analysis of Custom Synthetic Genes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Custom Synthetic Genes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Custom Synthetic Genes in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Custom Synthetic Genes Industry Trends Table 2. Custom Synthetic Genes Industry Drivers Table 3. Custom Synthetic Genes Industry Opportunities and Challenges Table 4. Custom Synthetic Genes Industry Restraints Table 5. Global Custom Synthetic Genes Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Custom Synthetic Genes Revenue Share by Company (2021-2026) Table 7. Global Custom Synthetic Genes Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Custom Synthetic Genes Key Company Manufacturing Base & Headquarters Table 9. Global Custom Synthetic Genes Company, Product Type & Application Table 10. Global Custom Synthetic Genes Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Custom Synthetic Genes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Above 5000 bp Table 15. Significant Companies of 3001- 5000 bp Table 16. Significant Companies of 1001 - 3000 bp Table 17. Significant Companies of Below 1000 bp Table 18. Global Custom Synthetic Genes Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Custom Synthetic Genes Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Custom Synthetic Genes Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Custom Synthetic Genes Sales Value Share by Type (2021-2026) Table 22. Global Custom Synthetic Genes Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Commercial Table 24. Significant Companies of Academic Research Table 25. Global Custom Synthetic Genes Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Custom Synthetic Genes Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Custom Synthetic Genes Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Custom Synthetic Genes Sales Value Share by Application (2021-2026) Table 29. Global Custom Synthetic Genes Sales Value Share by Application (2027-2032) Table 30. Global Custom Synthetic Genes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Custom Synthetic Genes Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Custom Synthetic Genes Sales Value Share by Region (2021-2026) Table 33. Global Custom Synthetic Genes Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Custom Synthetic Genes Sales Value Share by Region (2027-2032) Table 35. Global Custom Synthetic Genes Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Custom Synthetic Genes Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Custom Synthetic Genes Sales Value Market Share by Country (2021-2026) Table 38. Global Custom Synthetic Genes Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Custom Synthetic Genes Sales Value Market Share by Country (2027-2032) Table 40. Azenta Life Sciences Company Information Table 41. Azenta Life Sciences Business Overview Table 42. Azenta Life Sciences Custom Synthetic Genes Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Azenta Life Sciences Custom Synthetic Genes Product Portfolio Table 44. Azenta Life Sciences Recent Development Table 45. BBI Company Information Table 46. BBI Business Overview Table 47. BBI Custom Synthetic Genes Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. BBI Custom Synthetic Genes Product Portfolio Table 49. BBI Recent Development Table 50. Bio Basic Company Information Table 51. Bio Basic Business Overview Table 52. Bio Basic Custom Synthetic Genes Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Bio Basic Custom Synthetic Genes Product Portfolio Table 54. Bio Basic Recent Development Table 55. DNA 2.0 (ATUM) Company Information Table 56. DNA 2.0 (ATUM) Business Overview Table 57. DNA 2.0 (ATUM) Custom Synthetic Genes Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. DNA 2.0 (ATUM) Custom Synthetic Genes Product Portfolio Table 59. DNA 2.0 (ATUM) Recent Development Table 60. Eurofins Genomics Company Information Table 61. Eurofins Genomics Business Overview Table 62. Eurofins Genomics Custom Synthetic Genes Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Eurofins Genomics Custom Synthetic Genes Product Portfolio Table 64. Eurofins Genomics Recent Development Table 65. Genescript Company Information Table 66. Genescript Business Overview Table 67. Genescript Custom Synthetic Genes Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Genescript Custom Synthetic Genes Product Portfolio Table 69. Genescript Recent Development Table 70. IDT Company Information Table 71. IDT Business Overview Table 72. IDT Custom Synthetic Genes Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. IDT Custom Synthetic Genes Product Portfolio Table 74. IDT Recent Development Table 75. OriGene Company Information Table 76. OriGene Business Overview Table 77. OriGene Custom Synthetic Genes Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. OriGene Custom Synthetic Genes Product Portfolio Table 79. OriGene Recent Development Table 80. SBS Genetech Company Information Table 81. SBS Genetech Business Overview Table 82. SBS Genetech Custom Synthetic Genes Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. SBS Genetech Custom Synthetic Genes Product Portfolio Table 84. SBS Genetech Recent Development Table 85. Thermo Scientific Company Information Table 86. Thermo Scientific Business Overview Table 87. Thermo Scientific Custom Synthetic Genes Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Thermo Scientific Custom Synthetic Genes Product Portfolio Table 89. Thermo Scientific Recent Development Table 90. Twist Bioscience Company Information Table 91. Twist Bioscience Business Overview Table 92. Twist Bioscience Custom Synthetic Genes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Twist Bioscience Custom Synthetic Genes Product Portfolio Table 94. Twist Bioscience Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Custom Synthetic Genes Product Image Figure 2. Global Custom Synthetic Genes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Custom Synthetic Genes Market Size (2021-2032) & (US$ Million) Figure 4. Global Custom Synthetic Genes Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Above 5000 bp Image Figure 8. 3001- 5000 bp Image Figure 9. 1001 - 3000 bp Image Figure 10. Below 1000 bp Image Figure 11. Global Custom Synthetic Genes Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Custom Synthetic Genes Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Custom Synthetic Genes Sales Value Share by Type (2021-2032) Figure 14. Commercial Image Figure 15. Academic Research Image Figure 16. Global Custom Synthetic Genes Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Custom Synthetic Genes Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Custom Synthetic Genes Sales Value Share by Application (2021-2032) Figure 19. Global Custom Synthetic Genes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Custom Synthetic Genes Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Custom Synthetic Genes Sales Value (2021-2032) & (US$ Million) Figure 22. North America Custom Synthetic Genes Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Custom Synthetic Genes Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Custom Synthetic Genes Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Custom Synthetic Genes Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Custom Synthetic Genes Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Custom Synthetic Genes Sales Value (2021-2032) & (US$ Million) Figure 28. South America Custom Synthetic Genes Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Custom Synthetic Genes Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Custom Synthetic Genes Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Custom Synthetic Genes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Above 5000 bp
  • 3001- 5000 bp
  • 1001 - 3000 bp
  • Below 1000 bp
Applications
  • Commercial
  • Academic Research
Companies covered
  • Azenta Life Sciences
  • BBI
  • Bio Basic
  • DNA 2.0 (ATUM)
  • Eurofins Genomics
  • Genescript
  • IDT
  • OriGene
  • SBS Genetech
  • Thermo Scientific
  • Twist Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Custom Synthetic Genes Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Custom Synthetic Genes Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Custom Synthetic Genes Market Dynamics
  1. 2.1 Custom Synthetic Genes Industry Trends
  2. 2.2 Custom Synthetic Genes Industry Drivers
  3. 2.3 Custom Synthetic Genes Industry Opportunities and Challenges
  4. 2.4 Custom Synthetic Genes Industry Restraints
3 Custom Synthetic Genes Market by Company
  1. 3.1 Global Custom Synthetic Genes Company Revenue Ranking in 2025
  2. 3.2 Global Custom Synthetic Genes Revenue by Company (2021-2026)
  3. 3.3 Global Custom Synthetic Genes Company Ranking (2024-2026)
  4. 3.4 Global Custom Synthetic Genes Company Manufacturing Base and Headquarters
  5. 3.5 Global Custom Synthetic Genes Company Product Type and Application
  6. 3.6 Global Custom Synthetic Genes Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Custom Synthetic Genes Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Custom Synthetic Genes Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Custom Synthetic Genes Market by Type
  1. 4.1 Custom Synthetic Genes Type Introduction
  2. 4.1.1 Above 5000 bp
  3. 4.1.2 3001- 5000 bp
  4. 4.1.3 1001 - 3000 bp
  5. 4.1.4 Below 1000 bp
  6. 4.2 Global Custom Synthetic Genes Sales Value by Type
  7. 4.2.1 Global Custom Synthetic Genes Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Custom Synthetic Genes Sales Value by Type (2021-2032)
  9. 4.2.3 Global Custom Synthetic Genes Sales Value Share by Type (2021-2032)
5 Custom Synthetic Genes Market by Application
  1. 5.1 Custom Synthetic Genes Application Introduction
  2. 5.1.1 Commercial
  3. 5.1.2 Academic Research
  4. 5.2 Global Custom Synthetic Genes Sales Value by Application
  5. 5.2.1 Global Custom Synthetic Genes Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Custom Synthetic Genes Sales Value by Application (2021-2032)
  7. 5.2.3 Global Custom Synthetic Genes Sales Value Share by Application (2021-2032)
6 Custom Synthetic Genes Regional Value Analysis
  1. 6.1 Global Custom Synthetic Genes Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Custom Synthetic Genes Sales Value by Region (2021-2032)
  3. 6.2.1 Global Custom Synthetic Genes Sales Value by Region: 2021-2026
  4. 6.2.2 Global Custom Synthetic Genes Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Custom Synthetic Genes Sales Value (2021-2032)
  7. 6.3.2 North America Custom Synthetic Genes Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Custom Synthetic Genes Sales Value (2021-2032)
  10. 6.4.2 Europe Custom Synthetic Genes Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Custom Synthetic Genes Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Custom Synthetic Genes Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Custom Synthetic Genes Sales Value (2021-2032)
  16. 6.6.2 South America Custom Synthetic Genes Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Custom Synthetic Genes Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Custom Synthetic Genes Sales Value Share by Country, 2025 VS 2032
7 Custom Synthetic Genes Country-level Value Analysis
  1. 7.1 Global Custom Synthetic Genes Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Custom Synthetic Genes Sales Value by Country (2021-2032)
  3. 7.2.1 Global Custom Synthetic Genes Sales Value by Country (2021-2026)
  4. 7.2.2 Global Custom Synthetic Genes Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Custom Synthetic Genes Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Custom Synthetic Genes Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Custom Synthetic Genes Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Azenta Life Sciences
  2. 8.1.1 Azenta Life Sciences Company Information
  3. 8.1.2 Azenta Life Sciences Business Overview
  4. 8.1.3 Azenta Life Sciences Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Azenta Life Sciences Custom Synthetic Genes Product Portfolio
  6. 8.1.5 Azenta Life Sciences Recent Developments
  7. 8.2 BBI
  8. 8.2.1 BBI Company Information
  9. 8.2.2 BBI Business Overview
  10. 8.2.3 BBI Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BBI Custom Synthetic Genes Product Portfolio
  12. 8.2.5 BBI Recent Developments
  13. 8.3 Bio Basic
  14. 8.3.1 Bio Basic Company Information
  15. 8.3.2 Bio Basic Business Overview
  16. 8.3.3 Bio Basic Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bio Basic Custom Synthetic Genes Product Portfolio
  18. 8.3.5 Bio Basic Recent Developments
  19. 8.4 DNA 2.0 (ATUM)
  20. 8.4.1 DNA 2.0 (ATUM) Company Information
  21. 8.4.2 DNA 2.0 (ATUM) Business Overview
  22. 8.4.3 DNA 2.0 (ATUM) Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DNA 2.0 (ATUM) Custom Synthetic Genes Product Portfolio
  24. 8.4.5 DNA 2.0 (ATUM) Recent Developments
  25. 8.5 Eurofins Genomics
  26. 8.5.1 Eurofins Genomics Company Information
  27. 8.5.2 Eurofins Genomics Business Overview
  28. 8.5.3 Eurofins Genomics Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eurofins Genomics Custom Synthetic Genes Product Portfolio
  30. 8.5.5 Eurofins Genomics Recent Developments
  31. 8.6 Genescript
  32. 8.6.1 Genescript Company Information
  33. 8.6.2 Genescript Business Overview
  34. 8.6.3 Genescript Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Genescript Custom Synthetic Genes Product Portfolio
  36. 8.6.5 Genescript Recent Developments
  37. 8.7 IDT
  38. 8.7.1 IDT Company Information
  39. 8.7.2 IDT Business Overview
  40. 8.7.3 IDT Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  41. 8.7.4 IDT Custom Synthetic Genes Product Portfolio
  42. 8.7.5 IDT Recent Developments
  43. 8.8 OriGene
  44. 8.8.1 OriGene Company Information
  45. 8.8.2 OriGene Business Overview
  46. 8.8.3 OriGene Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  47. 8.8.4 OriGene Custom Synthetic Genes Product Portfolio
  48. 8.8.5 OriGene Recent Developments
  49. 8.9 SBS Genetech
  50. 8.9.1 SBS Genetech Company Information
  51. 8.9.2 SBS Genetech Business Overview
  52. 8.9.3 SBS Genetech Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SBS Genetech Custom Synthetic Genes Product Portfolio
  54. 8.9.5 SBS Genetech Recent Developments
  55. 8.10 Thermo Scientific
  56. 8.10.1 Thermo Scientific Company Information
  57. 8.10.2 Thermo Scientific Business Overview
  58. 8.10.3 Thermo Scientific Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Thermo Scientific Custom Synthetic Genes Product Portfolio
  60. 8.10.5 Thermo Scientific Recent Developments
  61. 8.11 Twist Bioscience
  62. 8.11.1 Twist Bioscience Company Information
  63. 8.11.2 Twist Bioscience Business Overview
  64. 8.11.3 Twist Bioscience Custom Synthetic Genes Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Twist Bioscience Custom Synthetic Genes Product Portfolio
  66. 8.11.5 Twist Bioscience Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst